Muhlis Cem Ar

22PUBLICATIONS
190CO-AUTHORS
Haematological tumoursMajor global burdens of diseaseHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 27, 2026
Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology.

|Jul 08, 2026
Haemophilia Management in Natural Disasters-From Field to Consensus Report.

|Jun 22, 2026
Citrullinated Histone 3 as a Marker of NETosis at Opposite Ends of Hemostasis: Evidence From Thrombosis-Prone MPN and Bleeding-Prone Hemophilia.

|Jun 03, 2026
National Perspectives on Academic CAR-T Cell Therapy in Türkiye: A Report from the Turkish Society of Hematology’s Scientific Subcommittee on Cell and Gene Therapies (TSH-CGT SSC)

|Jan 27, 2026
Early Antifungal Treatment in Immunocompromised Patients, Including Hematological and Critically Ill Patients.

Galina Klyasova, Galina Solopova, Jehad Abdalla

|Jan 06, 2026
Navigating biosimilar transitions in IV rituximab therapy: Efficacy and safety insights from a real-world switching study.

Abdülkadir Erçalışkan, Duygu Seyhan Erdoğan, Furkan Bahar

Pageof 4

Frequent Collaborators

6 joint publications

Ahmet Emre Eskazan

5 joint publications

Ahmet Muzaffer Demir

4 joint publications

İrfan Yavaşoğlu

4 joint publications

Selami Koçak Toprak